Did CEOs and officers buy or sell their own stock?
Open-market trades by the people who know the company best, with their own money.
Last 7 days: the stocks insiders bought and sold most
Stocks Koreans hold most · disclosed Last 7 days · open-market trades only
Bought most
Sold most
Whalegun
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
CertaraCERT | Open-market buy | 25/11/11 | 25/11/12 | 24,096.38 sh | $8.30 | $199,999.95 | +1.0% | |
Leif E. PedersenPresident, Chief Commercal Off | CertaraCERT | Open-market sale10b5-1 plan | 25/09/09 | 25/09/11 | 51,224 sh | $10.92 | $559,366.08 | −40.9% |
Patrick F. SmithPresident, Drug Dev Solutions | CertaraCERT | Open-market sale10b5-1 plan | 24/10/07 | 24/10/08 | 5,409 sh | $11.03 | $59,661.27 | −9.7% |
Leif E. PedersenPresident, Chief Commercal Off | CertaraCERT | Open-market sale10b5-1 plan | 24/09/09 | 24/09/10 | 51,224 sh | $11.29 | $578,318.96 | −33.9% |
CertaraCERT | Open-market sale10b5-1 plan | 24/04/02 | 24/04/04 | 14,427 sh6 trades | $16.85avg. | $243,161.42 | −22.4% | |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale10b5-1 plan | 24/04/01 | 24/04/03 | 3,000 sh | $18.00 | $54,000 | −1.7% |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale10b5-1 plan | 24/03/04 | 24/03/05 | 3,000 sh | $18.28 | $54,840 | −1.8% |
Patrick F. SmithPresident, Drug Dev Solutions | CertaraCERT | Open-market sale10b5-1 plan | 24/02/20 | 24/02/21 | 5,000 sh | $18.00 | $90,000 | −8.3% |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale10b5-1 plan | 24/02/12 | 24/02/14 | 6,000 sh | $18.00 | $108,000 | −3.5% |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale10b5-1 plan | 23/12/26 | 23/12/27 | 6,000 sh | $18.00 | $108,000 | −3.4% |
Leif E. PedersenPresident, Chief Commercal Off | CertaraCERT | Open-market sale10b5-1 plan | 23/09/11 | 23/09/12 | 51,224 sh | $14.60 | $747,870.4 | −28.4% |
CertaraCERT | Open-market buy | 23/08/21–23/08/22 | 23/08/23 | 5,000 sh2 trades | $15.81avg. | $79,057.9 | +53.4% | |
Patrick F. SmithPresident, Integrated Drug Dev | CertaraCERT | Open-market sale10b5-1 plan | 23/06/05 | 23/06/06 | 19,104 sh | $21.55 | $411,691.2 | −24.2% |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale10b5-1 plan | 23/05/11 | 23/05/15 | 5,000 sh | $20.82 | $104,100 | −2.7% |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale10b5-1 plan | 23/04/14 | 23/04/17 | 5,000 sh | $23.66 | $118,300 | −2.7% |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale | 23/03/06 | 23/03/07 | 10,000 sh | $21.45 | $214,500 | −5.1% |
Richard M. TraynorSVP and General Counsel | CertaraCERT | Open-market sale | 23/02/02 | 23/02/03 | 15,000 sh | $20.00 | $300,000 | −7.2% |